fbpx Skip to main content

Genalyte ARTICLE

Bringing you the latest financial and strategic news from top leaders in life science.

Antibody from Sorrento Therapeutics Shows 100 Percent Inhibition of SARS-CoV-2, Halozyme Receives Massive Milestone Payment from Janssen, Genalyte & SD Blood Bank Fight COVID-19 Together

  • Published on 15th, May 2020
  • California
  • Author: Lauren Panetta

5/15/20 - Sorrento Therapeutics

STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In Preclinical Studies

5/14/20 - Lexent Bio

Lexent Bio Announces Use of its Liquid Biopsy Assay, Confera Dx, in a Peer-Reviewed Paper Published in the Journal Molecular Cancer Therapeutics

5/14/20 - Slone Partners

Slone Partners Places Ingo Chakravarty as President and Chief Executive Officer at Mesa Biotech

5/14/20 - BioSpace

Genentech's Double Checkpoint Inhibitor Combo Shows Promise in Lung Cancer

5/14/20 - Histogen

Histogen Publishes Preclinical Data on its HST 004 Spinal Disc Program

5/14/20 - Biocept

Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selector™ BRAF Kit for Clients' Use in Their Own Laboratories

5/14/20 - Halozyme

Halozyme To Receive $15 Million Milestone Payment From Janssen

5/14/20 - NewsWise

First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development

5/14/20 - FierceBiotech

Gossamer's Dupont jumps to Atara Biotherapeutics

5/14/20 - UC San Diego

Supercomputing Drug Screening For Deadly Heart Arrhythmias

5/14/20 - Atara Bio

Atara Biotherapeutics Names Cell Therapy & Oncology Leader Jakob Dupont, M.D. as Global Head of Research & Development

5/13/20 - CBS8

Genalyte and San Diego Blood Bank team up to fight COVID-19

5/13/20 - Ultragenyx

Ultragenyx Announces Positive Longer-term Results from First Three Cohorts of Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency

5/13/20 - 23andMe

23andMe Expands its Genetic Study of COVID-19

5/13/20 - BioPharma Dive

Roche unveils first data for new type of cancer immunotherapy

5/13/20 - BioPharma Dive

Allogene gives first look at an 'off the shelf' cell therapy for lymphoma

5/13/20 - Iovance

Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma